2024 Winter ASTROnews

Section Menu  

Reference Lists for the 2024 Winter ASTROnews

Page 2 - Editor's Notes
By Najeeb Mohideen, MD, FASTRO

  1. Rakshit S, Wager E, Hughes-Cromwick P, et al. How does medical inflation compare to inflation in the rest of the economy. Health System Tracker. https://www.healthsystemtracker.org/brief/how-does-medical-inflation-compare-to-inflation-in-the-rest-of-the-economy. Published July 26, 2023. Accessed January 24, 2024.
  2. Healing Works Foundation. Wave 2: U.S. Patient and Oncologist Awareness, Usage and Attitudes Toward Whole Person Integrative Oncology. Published on August 17, 2023. Accessed January 24, 2024. https://healingworksfoundation.org/CancerSurvey2023/.

Page 3 - Chair's Update - Moving Forward to the Benefit of Our Patients
By Jeff M. Michalski, MD, MBA, FASTRO

  1. Hoskin P, Sartor O, O’Sullivan JM, et al. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial. Lancet Oncol. 2014;15:1397–1406.
  2. Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385:1091–1103.
  3. Strosberg J, El-Haddad G, Wolin E, et al. Phase 3 trial of 177lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125-135.
  4. Tomlinson C. How to obtain authorized user status. American Society for Radiation Oncology. August 9, 2023. Accessed December 21, 2023. https://www.astro.org/Blog/August-2023/How-to-Obtain-Authorized-User-Status.
  5. Buatti J, Michalski J. Radiation Oncology’s Scope of Practice for Radiopharmaceuticals. ASTROnews Winter 2023:10-11.

Page 16 - Exercise Oncology: Improving Overall Health while Treating Cancer
By Colin Champ, MD

  1. Caan BJ, Cespedes Feliciano EM, Prado CM, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798. doi:10.1001/jamaoncol.2018.0137.
  2. Bradshaw PT. Body composition and cancer survival: a narrative review. Br J Cancer. October 2023:1-8. doi:10.1038/s41416-023-02470-0.
  3. Champ CE, Carpenter DJ, Diaz AK, et al. Resistance training for patients with cancer: A conceptual framework for maximizing strength, power, functional mobility, and body composition to optimize health and outcomes. Sports Med. 2023;53(1):75-89. doi:10.1007/S40279-022-01759-Z.
  4. EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA (EXERT-BC). ClinicalTrials.gov. Accessed on December 8, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT05747209.
  5. EXERT-BCN: An Exercise and Nutrition Regimen to Designed to Improve Body Composition After Treatment for Breast Cancer (EXERT-BCN). ClinicalTrials.gov. Accessed on December 8, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT05978960.
Copyright © 2024 American Society for Radiation Oncology